Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
Nanomaterials · 01.09.2023 · 13 (17) · 2476
DOI: 10.3390/nano13172476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 01.09.2023. Verfasst von Palmira Alessia Cavallaro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union and MIUR, European Social Fund-NOP Research and Innovation.
Abstract (Originalsprache)
Breast cancer represents the most common cancer type and one of the major leading causes of death in the female worldwide population. Overexpression of HER2, a transmembrane glycoprotein related to the epidermal growth factor receptor, results in a biologically and clinically aggressive breast cancer subtype. It is also the primary driver for tumor detection and progression and, in addition to being an important prognostic factor in women diagnosed with breast cancer, HER2 is a widely known therapeutic target for drug development. The aim of this review is to provide an updated overview of the main approaches for the diagnosis and treatment of HER2-positive breast cancer proposed in the literature over the past decade. We focused on the different targeting strategies involving antibodies and peptides that have been explored with their relative outcomes and current limitations that need to be improved. The review also encompasses a discussion on targeted peptides acting as probes for molecular imaging. By using different types of HER2-targeting strategies, nanotechnology promises to overcome some of the current clinical challenges by developing novel HER2-guided nanosystems suitable as powerful tools in breast cancer imaging, targeting, and therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
- Department of Environmental Engineering, University of Calabria, Via P. Bucci, 87036 Rende, Italy.
ORCID-Profile: Manuela Curcio, Catia Morelli, Antonella Leggio
Förderung
- European Union and MIUR, European Social Fund-NOP Research and Innovation
Zitieren
APA
Cavallaro, P. A., De Santo, M., Belsito, E. L., Longobucco, C., Curcio, M., Morelli, C., Pasqua, L., & Leggio, A. (2023). Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics. Nanomaterials, 13(17), 2476. https://doi.org/10.3390/nano13172476
Vancouver
Cavallaro PA, De Santo M, Belsito EL, Longobucco C, Curcio M, Morelli C, et al. Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics. Nanomaterials. 2023;13(17):2476. doi:10.3390/nano13172476
BibTeX
@article{Cavallaro2023,
author = {Cavallaro, Palmira Alessia and De Santo, Marzia and Belsito, Emilia Lucia and Longobucco, Camilla and Curcio, Manuela and Morelli, Catia and Pasqua, Luigi and Leggio, Antonella},
title = {Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics},
journal = {Nanomaterials},
year = {2023},
volume = {13},
number = {17},
pages = {2476},
doi = {10.3390/nano13172476}
}
EUVIMED